Matthew 25 Management Corp Boosts Eli Lilly Stake

Investment firm increases holding in pharmaceutical giant by 113.8%

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Matthew 25 Management Corp, an investment management firm, has significantly increased its position in Eli Lilly and Company (NYSE:LLY) during the third quarter. According to a recent 13F filing, the firm added 8,250 shares, boosting its total holding to 15,500 shares, a 113.8% increase. This makes Eli Lilly the 13th largest position in Matthew 25 Management Corp's portfolio, valued at $11.8 million.

Why it matters

Eli Lilly is one of the world's leading pharmaceutical companies, known for its innovative drugs and therapies. Matthew 25 Management Corp's increased stake in the company suggests the firm sees strong growth potential and confidence in Lilly's future performance.

The details

The 113.8% increase in Matthew 25 Management Corp's Eli Lilly position was achieved through the purchase of an additional 8,250 shares during the third quarter. This brings the firm's total holding to 15,500 shares, making up approximately 3.6% of its overall portfolio.

  • Matthew 25 Management Corp made the share purchases during the third quarter of the year.

The players

Matthew 25 Management Corp

An investment management firm that has significantly increased its stake in Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company known for its innovative drugs and therapies.

Got photos? Submit your photos here. ›

The takeaway

Matthew 25 Management Corp's increased investment in Eli Lilly suggests the firm sees strong growth potential in the pharmaceutical giant, underscoring the company's position as a leader in the industry.